227 related articles for article (PubMed ID: 34854020)
21. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
23.
Duan Y; Zhang Y; Peng W; Jiang P; Deng Z; Wu C
Pharmazie; 2020 Jun; 75(6):266-270. PubMed ID: 32539923
[No Abstract] [Full Text] [Related]
24. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
25. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
[TBL] [Abstract][Full Text] [Related]
26. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
[TBL] [Abstract][Full Text] [Related]
27. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma.
Liu C; Xing M; Wang L; Zhang K
Br J Biomed Sci; 2017 Apr; 74(2):90-94. PubMed ID: 28367740
[TBL] [Abstract][Full Text] [Related]
28. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
[TBL] [Abstract][Full Text] [Related]
30. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
31. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
32. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.
Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY
Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061
[TBL] [Abstract][Full Text] [Related]
33. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
34. Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.
Capriglione F; Verrienti A; Celano M; Maggisano V; Sponziello M; Pecce V; Gagliardi A; Giacomelli L; Aceti V; Durante C; Bulotta S; Russo D
Endocrine; 2022 Jan; 75(1):185-193. PubMed ID: 34378123
[TBL] [Abstract][Full Text] [Related]
35. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
[TBL] [Abstract][Full Text] [Related]
36. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis.
Zhang L; Li H; Yuan M; Li D; Sun C; Wang G
Dis Markers; 2020; 2020():2456340. PubMed ID: 32076458
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
[TBL] [Abstract][Full Text] [Related]
38. Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer.
Rogucki M; Sidorkiewicz I; Niemira M; Dzięcioł JB; Buczyńska A; Adamska A; Siewko K; Kościuszko M; Maliszewska K; Wójcicka A; Supronik J; Szelachowska M; Reszeć J; Krętowski AJ; Popławska-Kita A
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681658
[TBL] [Abstract][Full Text] [Related]
39. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z
Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA signature predicts survival in papillary thyroid carcinoma.
Chengfeng X; Gengming C; Junjia Z; Yunxia L
J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
